Search results for "Surgical revascularization"

showing 4 items of 4 documents

Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Tri…

2021

Background: Patients with peripheral artery disease requiring lower extremity revascularization (LER) are at high risk of adverse limb and cardiovascular events. The VOYAGER PAD trial (Vascular Outcomes Study of ASA [Acetylsalicylic Acid] Along With Rivaroxaban in Endovascular or Surgical Limb Revascularization for PAD) demonstrated that rivaroxaban significantly reduced this risk. The efficacy and safety of rivaroxaban has not been described in patients who underwent surgical LER. Methods: The VOYAGER PAD trial randomized patients with peripheral artery disease after surgical and endovascular LER to rivaroxaban 2.5 mg twice daily plus aspirin or matching placebo plus aspirin and followed …

Lower extremity revascularizationMalemedicine.medical_specialtylower extremity revascularization; major adverse cardiovascular events (MACE); major adverse limb events (MALE); peripheral artery disease; revascularization; rivaroxaban.lower extremity revascularizationArterial diseasemedicine.medical_treatmentDiseaseRevascularizationperipheral artery diseasePeripheral Arterial DiseaseRivaroxabanPhysiology (medical)Internal medicinemedicineHumansIn patientmajor adverse cardiovascular events (MACE)major adverse limb events (MALE)AgedRivaroxabanAspirinAspirinbusiness.industryMiddle AgedCardiologyrevascularizationFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugSurgical revascularizationCirculation
researchProduct

Abstract 18060: Risk Stratification Following Mitral Valve Surgery for Chronic Ischemic Mitral Regurgitation: A Very Long-term Study

2015

Background: Very few long-term data are available on patients undergoing mitral valve surgery for chronic ischemic mitral regurgitation (CIMR). Objective:to identify determinants of survival and adverse cardiovascular events, at very long-term outcome. Methods and Results: We reviewed complete left and right ventricular echocardiographic data, six-minute walking test (6-MWT) and BNP levels at pre, peri and follow-up, on 137 consecutive patients who underwent restrictive mitral annuloplasty (RMA) or mitral valve replacement (MVR) and CABG, for CIMR. Combined adverse cardiovascular events were defined as composite of death, heart failure, angina, myocardial infarction and re-hospitalization.…

medicine.medical_specialtyLong term learningIschemic mitral regurgitationbusiness.industryPhysiology (medical)Internal medicineRisk stratificationmedicineCardiologyCardiology and Cardiovascular MedicinebusinessMitral valve surgerySurgical revascularizationCirculation
researchProduct

Coronary artery dissection. Follow-up by MDCT.

2009

and a feature consistent with a thrombus, probably located in the false lumen (Figure, D). Based on these findings, a new coronary angiography with possible surgical revascularization was planned, but 12 hours after the MDCT examination, the patient experienced an episode of chest pain with ST-segment elevation from V1 to V5, complicated by electromechanical dissociation, and culminating in death. A post-mortem study was not performed. This case illustrates the usefulness of MDCT for follow-up of coronary stents located in proximal segments, and for identifying specific complications: extension of a dissection and even visualization of a coronary thrombus.

Coronary angiographyAged 80 and overMalemedicine.medical_specialtybusiness.industryFalse lumenGeneral MedicineDissection (medical)Coronary Artery Diseasemedicine.diseaseChest painCoronary thrombuscardiovascular systemmedicineHumansStentscardiovascular diseasesRadiologyThrombusmedicine.symptombusinessArtery dissectionTomography X-Ray ComputedSurgical revascularizationRevista espanola de cardiologia
researchProduct

Critical limb ischaemia: definition and natural hystory

2004

The term critical limb ischemia refers to a condition characterized by chronic ischemic at-rest pain, ulcers, or gangrene in one or both legs attributable to objectively proven arterial occlusive disease. Critical limb ischemia implies chronicity and is to be distinguished from acute limb ischemia. Its incidence is approximately 500 to 1000 per million year, with the highest rates among older subjects, smokers and diabetics. The rate of primary amputation ranges from 10% to 40%, and was performed only when no graftable distal vessels were present, or in neurologically impaired or hopelessly nonambulatory patients. Contrarily, in some highly specialized and aggressive centres about 90% of pa…

critical limb ischemiamedicine.medical_specialtyArteriosclerosismedicine.medical_treatmentRevascularizationAmputation SurgicalGangrenearterial occlusive diseaseIschemiaRisk Factorscardiovascular mortalityInternal medicinePeripheral arterial diseaseMedicineHumansMyocardial infarctionStrokePharmacologyGangrenePeripheral Vascular DiseasesLegbusiness.industryFootcardiovascular morbiditysurgical revascularizationHematologyCritical limb ischemiamedicine.diseaseIntermittent claudicationFontaine’s classificationSurgerybody regionsNatural historyAmputationrisk factors amputationCardiologyMolecular Medicinemedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct